Literature DB >> 11898507

Chronic daily headache.

M J Láinez1, M J Monzón.   

Abstract

Chronic daily headache (CDH) is a heterogeneous group of headaches that includes primary and secondary varieties. Primary CDH is a frequent entity that probably affects 4% to 5% of the population. It can be subdivided into headaches of short duration (less than 4 hours per attack), like chronic cluster headache, and disorders of long duration (greater than 4 hours per attack). Primary CDH of long duration includes transformed migraine, chronic tension-type headache, new daily persistent headache, and hemicrania continua. Analgesic or ergot overuse is frequent in all types of CDH. We review recent insights into the proposed classification, epidemiology, pathophysiology, clinical characteristics, and treatment of CDH.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11898507     DOI: 10.1007/s11910-001-0006-x

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  43 in total

1.  Perfusion weighted imaging during migraine: spontaneous visual aura and headache.

Authors:  M Sanchez del Rio; D Bakker; O Wu; R Agosti; D D Mitsikostas; L Ostergaard; W A Wells; B R Rosen; G Sorensen; M A Moskowitz; F M Cutrer
Journal:  Cephalalgia       Date:  1999-10       Impact factor: 6.292

2.  Transformed migraine: a proposal for the modification of its diagnostic criteria based on recent epidemiological data.

Authors:  V Guitera; P Muñoz; J Castillo; J Pascual
Journal:  Cephalalgia       Date:  1999-12       Impact factor: 6.292

Review 3.  Chronic daily headache.

Authors:  S D Silberstein; R B Lipton
Journal:  Curr Opin Neurol       Date:  2000-06       Impact factor: 5.710

4.  Drug-induced headache: long-term results of stationary versus ambulatory withdrawal therapy.

Authors:  B Suhr; S Evers; B Bauer; I Gralow; K H Grotemeyer; I W Husstedt
Journal:  Cephalalgia       Date:  1999-01       Impact factor: 6.292

Review 5.  Systematic review of randomized clinical trials of complementary/alternative therapies in the treatment of tension-type and cervicogenic headache.

Authors:  H Vernon; C S McDermaid; C Hagino
Journal:  Complement Ther Med       Date:  1999-09       Impact factor: 2.446

Review 6.  Chronic refractory headache.

Authors:  N T Mathew
Journal:  Neurology       Date:  1993-06       Impact factor: 9.910

7.  A review of paroxysmal hemicranias, SUNCT syndrome and other short-lasting headaches with autonomic feature, including new cases.

Authors:  P J Goadsby; R B Lipton
Journal:  Brain       Date:  1997-01       Impact factor: 13.501

8.  Neural activation during acute capsaicin-evoked pain and allodynia assessed with PET.

Authors:  M J Iadarola; K F Berman; T A Zeffiro; M G Byas-Smith; R H Gracely; M B Max; G J Bennett
Journal:  Brain       Date:  1998-05       Impact factor: 13.501

9.  MRI of the occipital cortex, red nucleus, and substantia nigra during visual aura of migraine.

Authors:  K M Welch; Y Cao; S Aurora; G Wiggins; E M Vikingstad
Journal:  Neurology       Date:  1998-11       Impact factor: 9.910

10.  Global cerebral blood flow, blood volume, and oxygen metabolism in patients with migraine headache.

Authors:  E M Bednarczyk; B Remler; C Weikart; A D Nelson; R C Reed
Journal:  Neurology       Date:  1998-06       Impact factor: 9.910

View more
  2 in total

Review 1.  [A chronic problem-the chronic headache patient].

Authors:  A Straube
Journal:  Schmerz       Date:  2004-10       Impact factor: 1.107

Review 2.  [Therapy of primary chronic headache: chronic migraine, chronic tension type headache and other forms of daily chronic headache].

Authors:  A Straube; A May; P Kropp; Z Katsarava; G Haag; C Lampl; P S Sándor; H-C Diener; S Evers
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.